🇺🇸 FDA
Patent

US 6713081

Ocular therapeutic agent delivery devices and methods for making and using such devices

expired A61KA61K31/565A61K31/58

Quick answer

US patent 6713081 (Ocular therapeutic agent delivery devices and methods for making and using such devices) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/565, A61K31/58, A61K38/13, A61K9/0051